Dataset Information


CD99-PTPN12 Axis Suppresses Actin Cytoskeleton-Mediated Dimerization of Epidermal Growth Factor Receptor.

ABSTRACT: The epidermal growth factor receptor (EGFR), a member of ErbB receptor tyrosine kinase (RTK) family, is activated through growth factor-induced reorganization of the actin cytoskeleton and subsequent dimerization. We herein explored the molecular mechanism underlying the suppression of ligand-induced EGFR dimerization by CD99 agonists and its relevance to tumor growth in vivo. Epidermal growth factor (EGF) activated the formation of c-Src/focal adhesion kinase (FAK)-mediated intracellular complex and subsequently induced RhoA-and Rac1-mediated actin remodeling, resulting in EGFR dimerization and endocytosis. In contrast, CD99 agonist facilitated FAK dephosphorylation through the HRAS/ERK/PTPN12 signaling pathway, leading to inhibition of actin cytoskeletal reorganization via inactivation of the RhoA and Rac1 signaling pathways. Moreover, CD99 agonist significantly suppressed tumor growth in a BALB/c mouse model injected with MDA-MB-231 human breast cancer cells. Taken together, these results indicate that CD99-derived agonist ligand inhibits epidermal growth factor (EGF)-induced EGFR dimerization through impairment of cytoskeletal reorganization by PTPN12-dependent c-Src/FAK inactivation, thereby suppressing breast cancer growth.

PROVIDER: S-EPMC7599698 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC5908744 | BioStudies
| S-EPMC1366621 | BioStudies
| S-EPMC4931914 | BioStudies
| S-EPMC1877111 | BioStudies
| S-EPMC5835389 | BioStudies
| S-EPMC4187709 | BioStudies
| S-EPMC2755694 | BioStudies
| S-EPMC3431376 | BioStudies
| S-EPMC5814225 | BioStudies
| S-EPMC5658194 | BioStudies